Home
About
FAQ
History (23)
Therapeutic Potential of Glucagon-Like Peptide-1 Cleavage Product for Alzheimer's Disease.
The management of complications of small joint arthrodesis and arthroplasty.
Brain-specific repression of AMPKa1 alleviates pathophysiology in Alzheimer's model mice.
Surrogates of protection in repeated low-dose challenge experiments.
Brain cholesterol metabolism, oxysterols, and dementia.
See All 23 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Brain cholesterol metabolism, oxysterols, and dementia.
Hughes TM, Rosano C, Evans RW, Kuller LH. Brain cholesterol metabolism, oxysterols, and dementia. J Alzheimers Dis. 2013; 33(4):891-911.
View in:
PubMed
subject areas
Animals
Case-Control Studies
Cholesterol
Dementia
Humans
Hydroxycholesterols
authors with profiles
Timothy M. Hughes PhD